FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to immunology and medicine. What is presented is a method for preventing or treating an ocular condition related to high expression or activity of a complement factor D involving administering an antibody or its antigen-binding fragment into an individual. There are presented an anti-factor D 20D12 antibody and its antigen-binding fragment to be used to prepare a therapeutic agent, as well as containing the above antibody or its antigen-binding fragment, a kit for treating the ocular condition related to high activity or expression of factor D.
EFFECT: invention can find further application in therapy of the complement system related diseases.
14 cl, 6 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
C3b ANTIBODIES AND METHODS FOR PREVENTION AND TREATMENT OF COMPLEMENT-RELATED DISORDERS | 2008 |
|
RU2473563C2 |
APPLICATION OF COMPLEMENT PATHWAY INHIBITORS FOR TREATMENT OF EYE DISEASES | 2006 |
|
RU2417099C2 |
USE OF COMPLEMENT PATHWAY INHIBITORS TO TREAT OCULAR DISEASES | 2010 |
|
RU2583927C2 |
ANTIBODY TO COMPLEMENT Bb FACTOR | 2015 |
|
RU2673036C2 |
IMPROVED METHODS FOR OBTAINING LIBRARIES OF POLYNUCLEOTIDES IN SMALLPOX VIRUSES/EUKARYOTIC CELLS | 2017 |
|
RU2747557C2 |
ANTI-C5a ANTIBODIES AND THEIR APPLICATIONS | 2018 |
|
RU2773779C2 |
MOLECULES WHICH BIND TO PSL PSEUDOMONAS, AND METHODS FOR USE THEREOF | 2012 |
|
RU2708977C2 |
ANTI-panNrp ANTIBODY (VERSIONS) | 2007 |
|
RU2454427C2 |
NOVEL ANTIBODIES | 2008 |
|
RU2490277C2 |
LIBRARY OF CONCENTRATION-DEPENDENT ION BINDING MOLECULES | 2012 |
|
RU2812861C1 |
Authors
Dates
2014-07-20—Published
2008-05-22—Filed